White Paper

A Holistic Strategy To Ensure Container Closure Integrity Of Sterile Injectable Vial Product

Derek Duncan, Ph.D., Director Product Line, Lighthouse Instruments

Syringe vaccine

Recent regulatory guidance has triggered changes in industry best practices in the area of container closure integrity testing (CCIT). The increasing implementation of deterministic analytical methods for CCIT has enabled deeper insight into the performance of primary packaging with respect to container closure integrity (CCI). However, assuring good CCI of sterile injectable product goes beyond CCI testing. A more science-based holistic approach that includes robust design & qualification of the process and the implementation of appropriate process controls is required. This article describes a framework enabling such a holistic approach to CCI that assures both the primary packaging and the process contribute to good CCI of sterile injectable vial product.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online